Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.2500 (-2.57%) ($6.2500 - $6.2500) on Wed. Nov. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.45% (three month average) | RSI | 44 | Latest Price | $6.2500(-2.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.6% a day on average for past five trading days. | Weekly Trend | CGEN advances 2.5% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(73%) ARKG(71%) ARKK(69%) IWO(67%) IBUY(65%) | Factors Impacting CGEN price | CGEN will decline at least -1.725% in a week (0% probabilities). VIXM(-53%) VXX(-36%) UUP(-11%) TLT(-8%) UNG(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.725% (StdDev 3.45%) | Hourly BBV | -2.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $6.46 | 5 Day Moving Average | $6.58(-5.02%) | 10 Day Moving Average | $6.59(-5.16%) | 20 Day Moving Average | $6.46(-3.25%) | To recent high | -11.6% | To recent low | 7.6% | Market Cap | $517m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |